COMPOSITIONS COMPRISING THYLAKOIDS USEFUL IN THE MODULATION OF THE INFLAMMATION PROCESS

Details for Australian Patent Application No. 2002317100 (hide)

Owner PURECELL TECHNOLOGIES INC.

Inventors PURCELL, Marc; ANDERSEN, Alain; BISSONNETTE, Elyse; DROUIN, Rejean

Pub. Number AU-A-2002317100

PCT Number PCT/CA02/01009

PCT Pub. Number WO2003/004042

Priority 2,381,830 15.04.02 CA; 60/301,832 02.07.01 US

Filing date 2 July 2002

Wipo publication date 21 January 2003

International Classifications

A61K 035/78 Medicinal preparations containing material or reaction products thereof with undetermined constitution

A61P 029/00 Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61K 031/60 - Salicylic acid

Event Publications

9 January 2003 Complete Application Filed

  Priority application(s): 2,381,830 15.04.02 CA; 60/301,832 02.07.01 US

22 May 2003 Application Open to Public Inspection

  Published as AU-A-2002317100

18 March 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002317101-EPHRIN AND EPH RECEPTOR MEDIATED IMMUNE MODULATION

2002317099-SYSTEM AND METHOD OF OBJECTORIENTED PERSISTENCE